Nafcillin

This classification denotes a beta-lactam antibiotic with the molecular formula C21H22N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4CNZ27M7RV, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo- but generally known as nafcillin, which bears US NIH Compound Identifier 8982. European Medicines Agency schedules Nafcillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09118MIG. The term NAFCILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). NAFCILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nafcillin under HS 29411090 and SITC 54131. As of Q4 2014, NAFCILLIN remains the US FDA Preferred Term for this commodity. Nafcillin bears US NLM identifiers UMLS ID C0027324 and NCI Concept Code C62053. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C1C2C(CCC1OCC)CCCC2.